Donna R. Cryer, JD, has channeled her personal experience as an IBD and liver transplant patient into professional advocacy as president and chief executive officer of the Global Liver Institute, the innovation and collaboration platform for the liver community.
A prolific speaker on national and international health trends in research, advocacy, and healthcare delivery system transformation, Mrs. Cryer was the first patient to lead the American Liver Foundation in its thirty six-year history, serving as Chair and Chief Executive Officer and for more than a decade led CryerHealth, a healthcare consulting firm providing strategic counsel to top biopharmaceutical companies, patient advocacy organizations, and emerging technology firms on patient engagement in health information technology, drug discovery, and clinical decision making.
Mrs. Cryer has been appointed to the Pan American Health Organization/WHO Technical Expert Panel on Viral Hepatitis, by the U.S. GAO to serve as the patient and consumer representative on the Health Information Policy Committee, the federal advisory body to the National Coordinator for HIT and is serving her second five-year term with the U.S. Food and Drug
Administration. In addition, Mrs. Cryer serves on the Executive Committee of the Forum for Collaborative HIV Research, the Boards of Directors of the Society for Participatory Medicine the Personalized Medicine Coalition, and The Taft School, as a PCOR Translation Center Technical Expert for the Patient Centered Outcomes Research Institute (PCORI), a member of Stakeholder Advisory Group to the NIH Learning Health System Research Collaboratory, an American Society of Clinical Oncology Guidelines Committee, and the ABIM Gastroenterology Specialty Board.
Mrs. Cryer received an undergraduate degree from Harvard/Radcliffe Colleges and a Juris Doctorate from the Georgetown University Law Center.